2023 Volume 8 Issue 1 Pages 16-20
Jidabokuippo is considered to be administered for subcutaneous hematoma due to trauma and postoperative subcutaneous swelling in the field of neurosurgery. However, there are no unified dosing criteria such as guidelines, and it is thought that it depends on the judgment of the attending neurosurgeon. We investigated the current state of administration of jidabokuippo in our neurosurgery department and examined its effects. It was considered to be effective against subcutaneous hematoma due to trauma and postoperative subcutaneous swelling. As for pain caused by trauma, it was difficult to judge the effect because there was no objectivity. It is expected to be effective against organized chronic subdural hematoma.